Stocks / Finance · Consumer finance
Enova International ENVA
Outside our quality screen, so we don’t track its dips. It’s 34% below its 52-week high.
Outside our quality screen, trading well below our fair value estimate.
Worth knowing
- Deepest drop from a 52-week high in over 3 years
- Share count down 16% in 2 years
From the data on this page, as of the last close. How we pick these
- Fair value est.
- $244.18+40%
- Market Value
- forming
- Off 52-wk high
- −34%
- Risk vs market
- Above marketbeta 1.34
5 bullish · 2 bearish See why
Repriced or dip?
Dip: business intact
The price is 34% below its 52-week high (Aug 14), but the business held up: revenue +6.0%, revenue growth rate +2.4 pts, earnings per share +15.6%.
Some numbers held up (revenue +6.0%, revenue growth rate +2.4 pts, earnings per share +15.6%), others slipped. The price is 34% below its 52-week high.
The price is 34% below its 52-week high, and the business changed too.
Within 10% of its 52-week high, so there is no dip to judge yet.
The evidence 7 numbers, high vs now
- Revenue, last 12 months$3.4B → $3.7B (+6.0%)held up
- Revenue growth rate+17.7% → +20.1% a year (+2.4 pts)held up
- Earnings per share, 12 months$13.53 → $15.64 (+15.6%)held up
- Shares outstanding−6.9% (fewer shares, each owns more)held up
- Stock vs its sector (Finance)stock −34%, sector median −5% since Aug 14changed
- Price fall vs business numbersprice −34%, revenue/EPS/FCF median +11% (shown, not scored)
- Valuation multipleP/E 19.6× at the high → 11.1× now (shown, not scored)
Business numbers as reported at the high (12 months to Jun 30, 2026) vs the latest filing (12 months to Sep 30, 2026). Each measure is scored from −1 (business changed) to +1 (business intact) and weighted: revenue, earnings per share, free cash flow, operating margin, revenue growth rate, share count, net cash and the move vs its sector. 60 or more reads as a dip, 40 or less as a repricing. Analyst estimates are not in our data, so they are not used. How to read it
Data-based read, not advice.
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
52-wk high: P/E 19.6×; 52-wk low: P/E 10.8×; now: P/E 11.1×.
| High | Low | Now | |
|---|---|---|---|
| Price | $265.45Aug 14 | $119.49Nov 18 | $173.94 |
| P/E | 19.6× | 10.8× | 11.1× |
What this means: a lower P/E than at the high means you pay less for each dollar of profit than buyers did then.
How it’s computed
Banks, insurers and lenders: cash flow includes deposits and loans, so a cash-flow model doesn't fit; we show P/E at each point instead. P/E = that day's close × diluted shares / 12-month net income, using only the filings that were public on that day.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
How the range is computed
Financials model (residual income). Same residual-income model as the base: cost of equity 9.5% ±1 point and return on equity 23.2% ±2 points. Bear = 10.5% and 21.2%; bull = 8.5% and 25.2%. A model estimate from public filings, not a forecast of where the price will go.
Price is below even the bear case.
What the price implies To be worth today’s price, ENVA would need a return on equity of about 19% a year; our estimate uses 23%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much ENVA moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings more than the market, and its own price swings are 3.6× the S&P 500’s.
- Beta vs S&P 500
- 1.34
- Volatility
- 46% vs 13% SPY
- Correlation SPY
- 0.37
- Correlation QQQ
- 0.26
How it ranks
Where ENVA stands vs every one of the 1,996 stocks we cover that has the number. Longer bar = better.
Top quarter on 1 of 3 measures
- Discount to fair value estimate40% · price below our base caseTop 24%of 1,314
- Dividends + buybacks yield3.3% · cash paid out or used to retire shares, vs market capTop 43%of 1,836
- Revenue growth, last 12 months+20% · vs the 12 months beforeTop 26%of 1,814
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
DCF $244.18
Financials model (residual income): book value $64.41 a share on Sep 30, 2026, plus the earnings above a 9.5% cost of equity. ROE 23.2%, the average of 26.7% for the trailing 12 months to Sep 30, 2026 and 19.8% over fiscal 2021–2025, on average common equity; payout 28% of earnings (dividends 0% + net buybacks 28%), so book grows by the retained rest; the return above 9.5% fades halfway toward 9.5% over 10 years, then grows at 3% (terminal value). From the 10-Q filed Oct 22, 2026.
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
ValuationOur residual-income fair value estimate is $244.18, 40% above the price.
GrowthDiluted EPS grew 55% to $11.52 in FY2025.
GrowthSales compounded 22% a year from FY2022 to FY2025.
GrowthSales grew 20% to $3.7B over the last 12 months vs the 12 months before (SEC filings).
ProfitabilityReturn on equity of 27% over the last 12 months, up 9 points in two years.
Top bearish points 2 of 5
ProfitabilityNet margin of 10%, below the 22% median for the 281 Finance companies we cover.
ValuationPrice / book of 2.7×, above the 1.7× median for the 296 Finance companies we cover.
All fundamentals
P/E 11.1 · ROE 27% · Sales +20%
Valuation
- P/E
- 11.1×Finance median 13.6×
- Price / FCF
- n/acash flow isn't a clean measure for a lender
- FCF yield
- n/acash flow isn't a clean measure for a lender
- EV / EBITDA
- n/anot meaningful for a lender
- Price / sales
- 1.16×
- Price / book
- 2.71×
- Market cap
- $4.3Bprice × diluted shares
- Enterprise value
- $9.5B
Growth
- Revenue, 12 months
- $3.7B
- Sales growth, 12 months
- +20.1%vs the 12 months before
- Sales growth, 3 yrs
- +22.0%/yrfrom FY2022
- Diluted EPS, 12 months
- $14.48
- EPS growth, last FY
- +55.0%
- Net income, 12 months
- $382M
- Net income growth
- +30%12 months vs before
Profitability
- Gross margin
- n/anot meaningful for a lender
- Operating margin
- 24.0%
- Net margin
- 10.5%
- FCF margin
- 54.9%
- Return on equity
- 27%
- Return on invested capital
- n/anot meaningful for a lender
Balance sheet
- Cash & short-term inv.
- $106M
- Total debt
- $5.4B
- Net cash
- n/anot meaningful for a lender
- Debt / equity
- n/adeposits/float make debt/equity not comparable for a lender
- Interest coverage
- n/anot meaningful for a lender
Cash flow & returns
- Free cash flow, 12 months
- $2.0B
- FCF growth, 12 months
- +18%
- Dividend yield
- n/ano dividend payments tagged
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- $141M3.3% of market cap
- Share count, 1 year
- −0.1%diluted shares vs a year ago
- Stock-based comp
- $35M
Trailing 12 months to Sep 30, 2026; balance sheet at Sep 30, 2026. From Enova International’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $2.0B · Sales +37%
- Free cash flow, 12 months$2.0B
- Free-cash-flow yield46.7%
- Return on equity27%
- Sales growth (latest quarter vs year-ago quarter)+37%
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $173.94
- 52-wk lowlowest close, 1 year$119.49−31.3%
- PriceMon Nov 2 close$173.94you are here
- Fair value est.base case$244.18+40.4%
- 52-wk highhighest close, 1 year$265.45+52.6%
Momentum & 52-week range
RSI 44 · 5 days +2.3%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
ENVA is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Enova International in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Consumer finance
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.